hexamethylene bisacetamide has been researched along with warfarin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Grainger, DJ; Hesketh, TR; Metcalfe, JC; Weissberg, PL | 1 |
| Kirsten, E; Kun, E; Kurian, P; Milo, GE | 1 |
3 other study(ies) available for hexamethylene bisacetamide and warfarin
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Hexamethylenebisacetamide selectively inhibits the proliferation of human and rat vascular smooth-muscle cells.
Topics: Acetamides; Animals; Cell Division; Cells, Cultured; Coumarins; DNA Replication; Endothelium, Vascular; Fibroblasts; Hematinics; Humans; Kinetics; Muscle, Smooth, Vascular; Quinazolines; Quinazolinones; Rats; Thymidine | 1992 |
Inhibition of carcinogen-induced cellular transformation of human fibroblasts by drugs that interact with the poly(ADP-ribose) polymerase system. Initial evidence for the development of transformation resistance.
Topics: Acetamides; Anti-Bacterial Agents; Benzamides; Butylated Hydroxyanisole; Carcinogens; Cell Transformation, Neoplastic; Coumarins; Fibroblasts; Humans; NAD+ Nucleosidase; Poly(ADP-ribose) Polymerase Inhibitors; Quercetin | 1985 |